Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
D014230:Triazoles; C041113:anaxirone